research funding database


This opportunity is currently closed.

Sign up for Content alerts to stay informed when this or related funding opportunities are posted.

Ulcerative Colitis (UC) Research (Europe | South Korea | Aust | NZ | Canada | Israel)

Share this post

ERC webinar 2024
ERC webinar 2024

The Ulcerative Colitis (UC) Research grant from Pfizer supports research proposals that advance our understanding of ulcerative colitis through research focused in the following areas:

  • For patients treated with S1P receptor modulators, exploration for optimal markers (including clinical, endoscopic, histologic, ultrasonographic, genetics, and other measured markers) to assess and potentially predict response to treatment
  • Correlation of effects of S1P receptor modulator and Microbiome
  • Elucidate the role of S1P receptor modulators in the treatment of extra-intestinal manifestations (EIM) of UC
  • Assess mechanistic association of S1P receptor modulation with reduced inflammation in colonic tissue beyond lymphocyte egress

Applicant must be affiliated with academic research institutions in European countries, Canada, South Korea, Australia, New Zealand or Israel. Applicants may apply for up to 200,000 USD (including 28% indirect costs).

Full applications are due on September 12, 2023.

The grant has closed Sign-up for our content alerts to be updated when it re-opens.

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

Sign-up for the
monthly funding newsletter

unsubscribe at any time